These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 288583)

  • 41. Detection of tumorigenic cells in Friend virus-infected mice: an in vivo methodological investigation.
    Moreau-Gachelin F; Wendling F; Bucau-Varlet P; Charon M; Tambourin P
    J Natl Cancer Inst; 1981 Jun; 66(6):1121-7. PubMed ID: 6941043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restored immune and nonimmune functions in Friend virus leukemic mice treated with statolon.
    Wheelock EF; Toy ST; Weislow OS; Levy MH
    Prog Exp Tumor Res; 1974; 19():369-89. PubMed ID: 4612609
    [No Abstract]   [Full Text] [Related]  

  • 43. Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.
    Bayer H; Hunsmann G
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():515-22. PubMed ID: 3469323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of serum from mice with dormant Friend leukemia viral infections on synthesis and modulation of erythroleukemia cell surface gp70.
    Callahan RM; Marx PA; Marum WG; Wheelock EF
    J Immunol; 1980 Aug; 125(2):616-22. PubMed ID: 6930443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.
    Doig D; Chesebro B
    J Exp Med; 1979 Jul; 150(1):10-9. PubMed ID: 286744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythroleukemia induction by replication-competent type C viruses cloned from the anemia- and polycythemia-inducing isolates of Friend leukemia virus.
    MacDonald ME; Mak TW; Bernstein A
    J Exp Med; 1980 Jun; 151(6):1493-503. PubMed ID: 6247414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Preliminary study on the effects induced by an anemic strain of Friend leukemia virus in DBA/2 mice].
    Del Gobbo V; Santucci L; Premrov MG; Favalli C; Rinaldi C; Jezzi T; Titti F
    Boll Soc Ital Biol Sper; 1980 Sep; 56(18):1829-32. PubMed ID: 7195261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restoration of leukemia virus-suppressed immunocytes in vitro by peritoneal exudate cells.
    Specter S; Patel N; Friedman H
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):163-7. PubMed ID: 943103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
    Afifi MS; Bennett M; Kumar V
    Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of genetic resistance to immune suppression by Friend leukemia virus: the role of marrow-dependent cells.
    Kumar V; Eckner RJ; Bennett M
    Ann N Y Acad Sci; 1976; 276():217-28. PubMed ID: 1088383
    [No Abstract]   [Full Text] [Related]  

  • 51. Discussion paper: protective immunity in leukemic mice treated with specific "immunogenic" RNA.
    Friedman H
    Ann N Y Acad Sci; 1976; 277(00):708-15. PubMed ID: 1069568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Target cell heterogeneity in murine leukemia virus infection. II. Demonstration of Friend leukemia-virus-permissive and non-permissive subsets of splenic T cells.
    Isaak DD; Cerny J
    Int J Cancer; 1981; 27(4):505-12. PubMed ID: 6974139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lysis of FLD-3 Friend erythroleukemia cells in vitro and in vivo: effect of 89Sr treatment and Friend virus infection.
    Lust JA; Bennett M; Kumar V
    Int J Cancer; 1984 Jan; 33(1):107-13. PubMed ID: 6582049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spontaneous regression of Friend virus-induced erythroleukemia IX. Role of complement in leukemia regression.
    Longley C; Furmanski P
    Leuk Res; 1982; 6(5):703-10. PubMed ID: 6961267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virus-induced immunodeficiency: antibody responsiveness of MuLV-infected spleen cells following transfer into irradiated mice.
    Toniolo A; Matteucci D; Conaldi PG; Bendinelli M
    Med Microbiol Immunol; 1984; 173(4):197-206. PubMed ID: 6513865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced antibody response in retrovirus-infected mice treated with endotoxin or nontoxic polysaccharide derivative.
    Friedman H; Butler RC; Nowotny A
    Proc Soc Exp Biol Med; 1987 Dec; 186(3):275-9. PubMed ID: 3423016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.
    Kumar V; Caruso T; Bennett M
    J Exp Med; 1976 Apr; 143(4):728-40. PubMed ID: 1082914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impairment of in vitro generation of cytotoxic or T suppressor lymphocytes by Friend leukemia virus infection in mice.
    Garaci E; Migliorati G; Jezzi T; Bartocci A; Gioia L; Rinaldi C; Bonmassar E
    Int J Cancer; 1981 Sep; 28(3):367-73. PubMed ID: 6459295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of infection of mice with Friend leukemia complex viruses on background antibody-forming cell production in vitro.
    Bendinelli M; Matteucci D; Toniolo A; Friedman H
    Experientia; 1978 Sep; 34(9):1161-2. PubMed ID: 569071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.